DK1114156T3 - Transformerende vækstfaktor Beta-9 (ZTGFSS9) fra pattedyr - Google Patents
Transformerende vækstfaktor Beta-9 (ZTGFSS9) fra pattedyrInfo
- Publication number
- DK1114156T3 DK1114156T3 DK99969114T DK99969114T DK1114156T3 DK 1114156 T3 DK1114156 T3 DK 1114156T3 DK 99969114 T DK99969114 T DK 99969114T DK 99969114 T DK99969114 T DK 99969114T DK 1114156 T3 DK1114156 T3 DK 1114156T3
- Authority
- DK
- Denmark
- Prior art keywords
- seq
- ztgfss9
- mammals
- growth factor
- transforming growth
- Prior art date
Links
- 241000124008 Mammalia Species 0.000 title 1
- 102000009618 Transforming Growth Factors Human genes 0.000 title 1
- 108010009583 Transforming Growth Factors Proteins 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Oncology (AREA)
- Physical Education & Sports Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15481798A | 1998-09-17 | 1998-09-17 | |
| PCT/US1999/021677 WO2000015798A2 (en) | 1998-09-17 | 1999-09-17 | Mammalian transforming growth factor beta - 9 (ztgfss9) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1114156T3 true DK1114156T3 (da) | 2008-03-03 |
Family
ID=22552920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99969114T DK1114156T3 (da) | 1998-09-17 | 1999-09-17 | Transformerende vækstfaktor Beta-9 (ZTGFSS9) fra pattedyr |
Country Status (11)
| Country | Link |
|---|---|
| EP (2) | EP1897948A1 (da) |
| JP (2) | JP2002525056A (da) |
| AT (1) | ATE378408T1 (da) |
| AU (1) | AU6050499A (da) |
| CA (2) | CA2343569C (da) |
| DE (1) | DE69937570T2 (da) |
| DK (1) | DK1114156T3 (da) |
| ES (1) | ES2300154T3 (da) |
| IL (1) | IL141869A0 (da) |
| WO (1) | WO2000015798A2 (da) |
| ZA (1) | ZA200101819B (da) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6562578B1 (en) | 1999-01-11 | 2003-05-13 | Schering Corporation | IL-17-like cytokine binding compounds and antibodies |
| DK1076703T4 (da) | 1998-05-15 | 2011-03-28 | Genentech Inc | Terapeutiske anvendelser af IL-17-homologe polypeptider |
| US7771719B1 (en) | 2000-01-11 | 2010-08-10 | Genentech, Inc. | Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E |
| EP1443055A3 (en) * | 1998-05-29 | 2005-06-08 | Human Genome Sciences, Inc. | Interleukins-21 and 22 |
| AR022236A1 (es) * | 1999-01-11 | 2002-09-04 | Schering Corp | Citoquinas mamiferas purificadas; reactivos y metodos relacionados |
| EP1897945B1 (en) * | 1999-12-23 | 2012-01-18 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
| US20040043397A1 (en) | 2000-01-11 | 2004-03-04 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
| US7718397B2 (en) | 2000-03-21 | 2010-05-18 | Genentech, Inc. | Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof |
| AU2001265157A1 (en) * | 2000-05-31 | 2001-12-11 | Zymogenetics Inc. | Mammalian transforming growth factor beta-10 |
| US20030096969A1 (en) | 2000-06-02 | 2003-05-22 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| CA2430257A1 (en) * | 2000-11-28 | 2002-06-06 | Amgen, Inc. | Transforming growth factor-beta-related molecules and uses thereof |
| ATE501730T1 (de) * | 2001-01-25 | 2011-04-15 | Zymogenetics Inc | Verfahren zur behandlung von psoriasis unter verwendung eines il-17d antagonisten |
| US20040259779A1 (en) * | 2001-07-06 | 2004-12-23 | Teit Johansen | Novel neurotrophic factors |
| GB0417487D0 (en) | 2004-08-05 | 2004-09-08 | Novartis Ag | Organic compound |
| AU2007317232A1 (en) * | 2006-11-08 | 2008-05-15 | Zymogenetics, Inc. | Variants and methods of using transforming growth factor beta-9 |
| CN104628855A (zh) | 2008-05-05 | 2015-05-20 | 诺维莫尼公司 | 抗il-17a/il-17f交叉反应性抗体及其使用方法 |
| PE20120815A1 (es) | 2009-05-05 | 2012-07-08 | Novimmune Sa | Anticuerpos anti il-17f y metodos de uso de los mismos |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5532159A (en) * | 1994-04-01 | 1996-07-02 | The Ohio State University | Monoclonal antibody to canine placental oncofetal protein for detecting cancer |
| PT839196E (pt) * | 1995-07-19 | 2005-09-30 | Inst Genetics Llc | Ctla-8 humana e utilizacoes de proteinas relacionadas com ctla-8 |
| JP4216343B2 (ja) * | 1997-04-25 | 2009-01-28 | ザイモジェネティクス，インコーポレイティド | 哺乳類サイトカイン様因子７ |
| US20030003545A1 (en) | 1998-05-29 | 2003-01-02 | Reinhard Ebner | Interleukins-21 and 22 |
| AR022236A1 (es) | 1999-01-11 | 2002-09-04 | Schering Corp | Citoquinas mamiferas purificadas; reactivos y metodos relacionados |
-
1999
- 1999-09-17 EP EP07017934A patent/EP1897948A1/en not_active Withdrawn
- 1999-09-17 IL IL14186999A patent/IL141869A0/xx unknown
- 1999-09-17 JP JP2000570325A patent/JP2002525056A/ja not_active Withdrawn
- 1999-09-17 DE DE69937570T patent/DE69937570T2/de not_active Expired - Lifetime
- 1999-09-17 AU AU60504/99A patent/AU6050499A/en not_active Abandoned
- 1999-09-17 CA CA2343569A patent/CA2343569C/en not_active Expired - Fee Related
- 1999-09-17 EP EP99969114A patent/EP1114156B1/en not_active Expired - Lifetime
- 1999-09-17 WO PCT/US1999/021677 patent/WO2000015798A2/en not_active Ceased
- 1999-09-17 DK DK99969114T patent/DK1114156T3/da active
- 1999-09-17 ES ES99969114T patent/ES2300154T3/es not_active Expired - Lifetime
- 1999-09-17 AT AT99969114T patent/ATE378408T1/de active
- 1999-09-17 CA CA2706859A patent/CA2706859A1/en not_active Abandoned
-
2001
- 2001-03-05 ZA ZA200101819A patent/ZA200101819B/en unknown
-
2010
- 2010-04-22 JP JP2010098890A patent/JP2010187691A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL141869A0 (en) | 2002-03-10 |
| ATE378408T1 (de) | 2007-11-15 |
| CA2706859A1 (en) | 2000-03-23 |
| EP1897948A1 (en) | 2008-03-12 |
| ZA200101819B (en) | 2001-09-27 |
| JP2002525056A (ja) | 2002-08-13 |
| ES2300154T3 (es) | 2008-06-01 |
| CA2343569A1 (en) | 2000-03-23 |
| DE69937570D1 (de) | 2007-12-27 |
| EP1114156B1 (en) | 2007-11-14 |
| JP2010187691A (ja) | 2010-09-02 |
| AU6050499A (en) | 2000-04-03 |
| WO2000015798A2 (en) | 2000-03-23 |
| WO2000015798A3 (en) | 2000-05-25 |
| CA2343569C (en) | 2010-09-14 |
| DE69937570T2 (de) | 2009-04-23 |
| EP1114156A2 (en) | 2001-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1114156T3 (da) | Transformerende vækstfaktor Beta-9 (ZTGFSS9) fra pattedyr | |
| IL210454A0 (en) | Novel cytokine zcytor17 ligand | |
| DK0839196T3 (da) | Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner | |
| DE60329070D1 (de) | Antikörper gegen den fibroblastenwachstumsfaktor 23 | |
| DE69824755D1 (de) | Cytokinähnliches polypeptid-10 aus säugetieren | |
| MY123740A (en) | Il-13 receptor polypeptide | |
| IL212140A0 (en) | Antibodies against acpl polypeptides | |
| DE69936105D1 (de) | Menschliche tslp nukleinsäuren und polypeptide | |
| EP1037999A4 (en) | POLYPEPTIDES AND NUCLEOTIDES PORPHYROMONAS GINGIVALIS | |
| EA201001190A1 (ru) | Выделенное антитело, специфически связанное с полипептидом, состоящее из последовательности аминокислотных остатков | |
| EP0546087A4 (da) | ||
| DE69929454D1 (de) | Neue aminosäuresequenzen, deren kodierende dns, antikörper dagegen und deren verwendungen | |
| DK0773999T3 (da) | OR-1, en orphan-receptor tilhørende kernereceptorfamilien | |
| NO921219D0 (no) | Somatostatin reseptor | |
| EA200100440A1 (ru) | Ген prv-1 и его применение | |
| EP1295943A4 (en) | POLYPEPTIDES CAPABLE THE POWER TO STIMULATE NEUTROPHILES | |
| NZ606260A (en) | Novel polypeptides involved in immune response |